A Pilot Study to Explore the Role of Gut Flora in Psoriasis

ProgenaBiome

Status

Withdrawn

Conditions

Psoriasis

Psoriasis Palmaris

Psoriasis Punctata

Psoriasis Genital

Psoriasis Face

Psoriasis Nail

Psoriasis of Scalp

Psoriasis Vulgaris

Psoriatic Plaque

Psoriasis Annularis

Psoriasis Circinata

Psoriasis Diffusa

Psoriasis Geographica

Psoriasis Universalis

Treatments

Other: No Intervention

Study type

Observational

Funder types

Other

Identifiers

NCT04099979

PRG-011

Details and patient eligibility

About

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Psoriasis.

Full description

The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to the information provided in surveys and in medical records regarding Psoriasis

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Signed informed consent by patient
Male or female patients age 18 and older.
Diagnosis of Psoriasis based on PSAI of greater than or equal to 12 at screening

Exclusion criteria

Refusal by patient to sign informed consent form
Treatment with antibiotics within 2 weeks prior to screening
Treatment with probiotics within 6 weeks prior to screening
History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
Postoperative stoma, ostomy, or ileoanal pouch
Participation in any experimental drug protocol within the past 12 weeks
Treatment with total parenteral nutrition
Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial
Inability of patient to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study